A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
This study has been completed.
First Posted: October 17, 2007
Last Update Posted: January 18, 2013
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||February 2012|
|Primary Completion Date:||December 2011 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||January 10, 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Sopata M, Katz N, Carey W, Smith MD, Keller D, Verburg KM, West CR, Wolfram G, Brown MT. Efficacy and safety of tanezumab in the treatment of pain from bone metastases. Pain. 2015 Sep;156(9):1703-13. doi: 10.1097/j.pain.0000000000000211.